WHO SMART Guidelines - HIV
0.3.0 - ci-build
WHO SMART Guidelines - HIV - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: http://smart.who.int/hiv/ValueSet/HIV.D.DE90 | Version: 0.3.0 | |||
| Active as of 2024-10-30 | Computable Name: HIVDDE90 | |||
Value set of list of ART regimens
References
Generated Narrative: ValueSet HIV.D.DE90
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.D.DE91 | ABC + 3TC + ATV/r | Regimen containing abacavir, lamivudine, and atazanavir/ritonavir |
| HIV.D.DE92 | ABC + 3TC + DTG | Regimen containing abacavir, lamivudine, and dolutegravir |
| HIV.D.DE93 | ABC + 3TC + EFV | Regimen containing abacavir, lamivudine, and efavarinez |
| HIV.D.DE94 | ABC + 3TC + LPV/r | Regimen containing abacavir, lamivudine, and lopinavir/ritonavir |
| HIV.D.DE95 | ABC + 3TC + NVP | Regimen containing abacavir, lamivudine, and nevirapine |
| HIV.D.DE96 | ABC + 3TC + RAL | Regimen containing abacavir, lamivudine, and raltegravir |
| HIV.D.DE97 | AZT + 3TC + ATV/r | Regimen containing zidovudine, lamivudine, and atazanavir/ritonavir |
| HIV.D.DE98 | AZT + 3TC + DRV/r | Regimen containing zidovudine, lamivudine, and darunavir/ritonavir |
| HIV.D.DE99 | AZT + 3TC + DTG | Regimen containing zidovudine, lamivudine, and dolutegravir |
| HIV.D.DE100 | AZT + 3TC + EFV | Regimen containing zidovudine, lamivudine, and efavirenz |
| HIV.D.DE101 | AZT + 3TC + EFV 600 mg | Regimen containing zidovudine, lamivudine, and efavirenz 600 mg |
| HIV.D.DE102 | AZT + 3TC + LPV/r | Regimen containing zidovudine, lamivudine, and lopinavir/ritonavir |
| HIV.D.DE103 | AZT + 3TC + NVP | Regimen containing zidovudine, lamivudine, and nevirapine |
| HIV.D.DE104 | AZT + 3TC + RAL | Regimen containing zidovudine, lamivudine, and raltegravir |
| HIV.D.DE105 | TAF + 3TC + DTG | Regimen containing tenofovir alafenamide, lamivudine, and dolutegravir |
| HIV.D.DE106 | TAF + FTC + DTG | Regimen containing tenofovir alafenamide, emtricitabine, and dolutegravir |
| HIV.D.DE107 | TDF + 3TC + ATV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and atazanavir/ritonavir |
| HIV.D.DE108 | TDF + 3TC + DRV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and darunavir/ritonavir |
| HIV.D.DE109 | TDF + 3TC + DTG | Regimen containing tenofovir disoproxil fumarate, lamivudine, and dolutegravir |
| HIV.D.DE110 | TDF + 3TC + EFV | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz |
| HIV.D.DE111 | TDF + 3TC + EFV 400 mg | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (400 mg) |
| HIV.D.DE112 | TDF + 3TC + EFV 600 mg | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (600 mg) |
| HIV.D.DE113 | TDF + 3TC + LPV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and lopinavir/ritonavir |
| HIV.D.DE114 | TDF + 3TC + NVP | Regimen containing tenofovir disoproxil fumarate, lamivudine, and nevirapine |
| HIV.D.DE115 | TDF + 3TC + PI/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and a boosted protease inhibitor |
| HIV.D.DE116 | TDF + 3TC + RAL | Regimen containing tenofovir disoproxil fumarate, lamivudine, and raltegravir |
| HIV.D.DE117 | TDF + FTC + ATV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and atazanavir/ritonavir |
| HIV.D.DE118 | TDF + FTC + DRV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and darunavir/ritonavir |
| HIV.D.DE119 | TDF + FTC + DTG | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and dolutegravir |
| HIV.D.DE120 | TDF + FTC + EFV | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz |
| HIV.D.DE121 | TDF + FTC + EFV 600 mg | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz (600 mg) |
| HIV.D.DE122 | TDF + FTC + LPV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and lopinavir/ritonavir |
| HIV.D.DE123 | TDF + FTC + NVP | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and nevirapine |
| HIV.D.DE124 | TDF + FTC + PI/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and a boosted protease inhibitor |
| HIV.D.DE125 | TDF + FTC + RAL | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and raltegravir |
| HIV.D.DE126 | Other | Other regimen based upon WHO recommendations |
Generated Narrative: ValueSet
Expansion based on codesystem WHO SMART HIV Concepts CodeSystem v0.3.0 (CodeSystem)
This value set contains 36 concepts
| Code | System | Display | Definition |
| HIV.D.DE91 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | ABC + 3TC + ATV/r | Regimen containing abacavir, lamivudine, and atazanavir/ritonavir |
| HIV.D.DE92 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | ABC + 3TC + DTG | Regimen containing abacavir, lamivudine, and dolutegravir |
| HIV.D.DE93 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | ABC + 3TC + EFV | Regimen containing abacavir, lamivudine, and efavarinez |
| HIV.D.DE94 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | ABC + 3TC + LPV/r | Regimen containing abacavir, lamivudine, and lopinavir/ritonavir |
| HIV.D.DE95 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | ABC + 3TC + NVP | Regimen containing abacavir, lamivudine, and nevirapine |
| HIV.D.DE96 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | ABC + 3TC + RAL | Regimen containing abacavir, lamivudine, and raltegravir |
| HIV.D.DE97 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | AZT + 3TC + ATV/r | Regimen containing zidovudine, lamivudine, and atazanavir/ritonavir |
| HIV.D.DE98 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | AZT + 3TC + DRV/r | Regimen containing zidovudine, lamivudine, and darunavir/ritonavir |
| HIV.D.DE99 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | AZT + 3TC + DTG | Regimen containing zidovudine, lamivudine, and dolutegravir |
| HIV.D.DE100 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | AZT + 3TC + EFV | Regimen containing zidovudine, lamivudine, and efavirenz |
| HIV.D.DE101 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | AZT + 3TC + EFV 600 mg | Regimen containing zidovudine, lamivudine, and efavirenz 600 mg |
| HIV.D.DE102 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | AZT + 3TC + LPV/r | Regimen containing zidovudine, lamivudine, and lopinavir/ritonavir |
| HIV.D.DE103 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | AZT + 3TC + NVP | Regimen containing zidovudine, lamivudine, and nevirapine |
| HIV.D.DE104 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | AZT + 3TC + RAL | Regimen containing zidovudine, lamivudine, and raltegravir |
| HIV.D.DE105 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TAF + 3TC + DTG | Regimen containing tenofovir alafenamide, lamivudine, and dolutegravir |
| HIV.D.DE106 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TAF + FTC + DTG | Regimen containing tenofovir alafenamide, emtricitabine, and dolutegravir |
| HIV.D.DE107 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + 3TC + ATV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and atazanavir/ritonavir |
| HIV.D.DE108 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + 3TC + DRV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and darunavir/ritonavir |
| HIV.D.DE109 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + 3TC + DTG | Regimen containing tenofovir disoproxil fumarate, lamivudine, and dolutegravir |
| HIV.D.DE110 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + 3TC + EFV | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz |
| HIV.D.DE111 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + 3TC + EFV 400 mg | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (400 mg) |
| HIV.D.DE112 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + 3TC + EFV 600 mg | Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (600 mg) |
| HIV.D.DE113 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + 3TC + LPV/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and lopinavir/ritonavir |
| HIV.D.DE114 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + 3TC + NVP | Regimen containing tenofovir disoproxil fumarate, lamivudine, and nevirapine |
| HIV.D.DE115 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + 3TC + PI/r | Regimen containing tenofovir disoproxil fumarate, lamivudine, and a boosted protease inhibitor |
| HIV.D.DE116 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + 3TC + RAL | Regimen containing tenofovir disoproxil fumarate, lamivudine, and raltegravir |
| HIV.D.DE117 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + FTC + ATV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and atazanavir/ritonavir |
| HIV.D.DE118 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + FTC + DRV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and darunavir/ritonavir |
| HIV.D.DE119 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + FTC + DTG | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and dolutegravir |
| HIV.D.DE120 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + FTC + EFV | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz |
| HIV.D.DE121 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + FTC + EFV 600 mg | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz (600 mg) |
| HIV.D.DE122 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + FTC + LPV/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and lopinavir/ritonavir |
| HIV.D.DE123 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + FTC + NVP | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and nevirapine |
| HIV.D.DE124 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + FTC + PI/r | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and a boosted protease inhibitor |
| HIV.D.DE125 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + FTC + RAL | Regimen containing tenofovir disoproxil fumarate, emtricitabine, and raltegravir |
| HIV.D.DE126 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | Other | Other regimen based upon WHO recommendations |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |